Biokine Therapeutics Announces Issuance of United States Patent covering the use of CXCR4 antagonist for wound healing

Biokine Therapeutics Announces Issuance of United States Patent covering the use of CXCR4 antagonist for wound healing and re-epithelialization (BKT170 Project). Read More

Investigator-Initiated Study for Novel Chronic Myeloid Leukemia Treatment

BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid Leukemia Treatment A phase 1/2 study will assess the effect of BKT-140/BL-8040 in combination with standard therapy. Read More

Go to Top